{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:35:27Z","timestamp":1787070927938,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Our study aims to analyse and compare the efficacy, adverse effect profile and survival among the Paclitaxel\/Cisplatin\/5-Flurouracil (TPF) induction chemotherapy and Paclitaxel\/carboplatin (PC) first line or cisplatin chemotherapy in a high-volume tertiary care cancer centre.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>215 patients with oral cavity cancer were recruited in this study. Patients with stages I-IIc underwent surgical resection or radiation therapy 66-74 GY\/fraction. Patients of Stages III-IV were administered with either induction chemotherapy TPF or PC or cisplatin regimen. Treatment responses were assessed by CT and MRI. Response rates, survival and adverse effects data were tabulated and analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The mean age was 49.2 \u00b1 11.68 years. Symptoms were ulceration (33.5%), growth (20.5%), pain (13%), ulcer-proliferative growth (8.4%) and swelling (13, 6%). The tumour site was found at the base of the tongue, C01 (42.2%) followed by C06 (35.8%), C08 (6.5%), C07 (5.2%) and C05 (4.6%). There were no significant differences (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05) in efficacy and survival outcomes between the different groups of treatment. Median survival was achieved within 36 months. The major side effect observed were anaemia (15.81%), diarrhoea (36.2%), dyspepsia (28.8%), fever (33.95%), mucositis (28.85%), myalgia (33.95%) and nausea (7.9%). Survival among the responder categories (CR, PR and NR) was significantly different as per Log-rank analysis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.015).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>TPF induction therapy and PC first line chemotherapy showed similar efficacy, safety profile and survival whereas cisplatin shows poor efficacy and safety and survival in Indian oral cancer patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_2179_22","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T13:01:55Z","timestamp":1706014915000},"page":"1006-1012","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Outcomes of 3-year follow up with induction vs first line chemotherapy in oral cancer patients: An observational hospital-based study"],"prefix":"10.4103","volume":"20","author":[{"given":"Pranab Kumar","family":"Sahoo","sequence":"first","affiliation":[{"name":"Department of Pathology and Cancer Screening, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India"},{"name":"Department of Pharmaceutical and Fine Chemical Technology, University of Calcutta, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup Kumar","family":"Bhowmick","sequence":"additional","affiliation":[{"name":"Department of ENT Oncology, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinjini","family":"Sarkar","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cancer Screening, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutapa","family":"Mahata","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cancer Screening, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranita","family":"Pal","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cancer Screening, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanuma","family":"Mistry","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cancer Screening, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cancer Screening, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Choudhury","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cancer Screening, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Suresh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, National Institute of Cancer Prevention, Noida, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syamsundar","family":"Mondal","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriparna","family":"Datta","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Fine Chemical Technology, University of Calcutta, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Nath","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cancer Screening, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India"},{"name":"Department of Medical Oncology, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyan Kusum","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilas D.","family":"Nasare","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cancer Screening, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1080\/14786419.2020.1831494","article-title":"Cytotoxic effect of pure compounds from piper rivinoides kunth against oral squamous cell carcinoma","volume":"35","author":"da Fonseca","year":"2021","journal-title":"Nat Prod Res"},{"key":"R2-20241021","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020:An overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int J cancer"},{"key":"R3-20241021","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.oraloncology.2008.05.016","article-title":"Potentially malignant disorders of the oral and oropharyngeal mucosa;Terminology, classification and present concepts of management","volume":"45","author":"van der Waal","year":"2009","journal-title":"Oral Oncol"},{"key":"R4-20241021","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/epirev\/mxw001","article-title":"The health system and policy implications of changing epidemiology for oral cavity and oropharyngeal cancers in the United States from to 2016","volume":"39","author":"LeHew","year":"2017","journal-title":"Epidemiol Rev"},{"key":"R5-20241021","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4103\/0973-1482.186696","article-title":"Oral cancer:Etiology and risk factors:A review","volume":"12","author":"Kumar","year":"2016","journal-title":"J Cancer Res Ther"},{"key":"R6-20241021","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1158\/1940-6207.CAPR-15-0091","article-title":"Leukoplakia, oral cavity cancer risk, and cancer survival in the U. S. Elderly","volume":"8","author":"Yanik","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"key":"R7-20241021","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J Clin Oncol"},{"issue":"(Suppl 18)","key":"R8-20241021","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1200\/jco.2006.24.18_suppl.5517","article-title":"Long-term results of Intergroup RTOG 91\u201311:A phase III trial to preserve the larynx\u2014Induction cisplatin\/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy","volume":"24","author":"Forastiere","year":"2006","journal-title":"J Clin Oncol"},{"key":"R9-20241021","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC):An update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"R10-20241021","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1200\/JCO.2012.43.8820","article-title":"Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma","volume":"31","author":"Zhong","year":"2013","journal-title":"J Clin Oncol"},{"key":"R11-20241021","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drup.2018.09.001","article-title":"Precision medicine in head and neck cancer","volume":"40","author":"Kaidar-Person","year":"2018","journal-title":"Drug Resist Updat"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11864-011-0176-y","article-title":"Current treatment options for metastatic head and neck cancer","volume":"13","author":"Price","year":"2012","journal-title":"Curr Treat Options Oncol"},{"key":"R13-20241021","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma:Three meta-analyses of updated individual data","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"R14-20241021","doi-asserted-by":"crossref","first-page":"22038","DOI":"10.18632\/oncotarget.25157","article-title":"Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent\/metastatic head and neck squamous cell carcinoma unfit to EXTREME schedule","volume":"9","author":"P\u00eatre","year":"2018","journal-title":"Oncotarget"},{"key":"R15-20241021","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.oraloncology.2019.08.001","article-title":"Comparison of GP and TPF induction chemotherapy for locally advanced nasopharyngeal carcinoma","volume":"97","author":"Zhu","year":"2019","journal-title":"Oral Oncol"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1159\/000494031","article-title":"Efficacy of carboplatin\/paclitaxel-based radiochemotherapy in locally advanced squamous cell carcinoma of Head and Neck","volume":"41","author":"Maring","year":"2018","journal-title":"Oncol Res Treat"},{"key":"R17-20241021","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ejca.2010.10.026","article-title":"Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma:Combined analyses of NPC-9901 and NPC-9902 Trials","volume":"47","author":"Lee","year":"2011","journal-title":"Eur J Cancer"},{"key":"R18-20241021","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1470-2045(10)70279-5","article-title":"Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck:Long-term results of the TA\u00d7324 randomised phase 3 trial","volume":"12","author":"Lorch","year":"2011","journal-title":"Lancet Oncol"},{"key":"R19-20241021","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.oraloncology.2018.02.011","article-title":"Optimizing the induction chemotherapy regimen for patients with locoregionally advanced nasopharyngeal Carcinoma:A big-data intelligence platform-based analysis","volume":"79","author":"Peng","year":"2018","journal-title":"Oral Oncol"},{"key":"R20-20241021","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2018.0026","article-title":"NCCN Guidelines Insights:Head and Neck Cancers, Version 1.2018","volume":"16","author":"Colevas","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"R21-20241021","doi-asserted-by":"crossref","first-page":"8636","DOI":"10.1200\/JCO.2004.00.1990","article-title":"Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer","volume":"23","author":"Hitt","year":"2005","journal-title":"J Clin Oncol"},{"key":"R22-20241021","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N Engl J Med"},{"key":"R23-20241021","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1002\/1097-0142(20011101)92:9<2334::AID-CNCR1580>3.0.CO;2-3","article-title":"Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinoma","volume":"92","author":"Clark","year":"2001","journal-title":"Cancer"},{"key":"R24-20241021","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archotol.130.7.837","article-title":"Diagnostic accuracy of magnetic resonance imaging in the assessment of mandibular involvement in oral-oropharyngeal squamous cell carcinoma:A prospective study","volume":"130","author":"Bolzoni","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R25-20241021","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1259\/dmfr\/69910245","article-title":"Comparison between computed tomography and clinical evaluation in tumour\/node stage and follow-up of oral cavity and oropharyngeal cancer","volume":"39","author":"Figueiredo","year":"2010","journal-title":"Dentomaxillofac Radiol"},{"key":"R26-20241021","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours:Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R27-20241021","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1470-2045(11)70320-5","article-title":"Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma:A phase 3 multicentre randomised controlled trial","volume":"13","author":"Chen","year":"2012","journal-title":"Lancet Oncol"},{"key":"R28-20241021","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejca.2017.01.002","article-title":"Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma:Long-term results of a phase 3 multicentre randomised controlled trial","volume":"75","author":"Chen","year":"2017","journal-title":"Eur J Cancer"},{"key":"R29-20241021","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/CEJ.0000000000000640","article-title":"Premalignant and malignant lesions of oral cavity in eastern India:A hospital-based study","volume":"30","author":"Sahoo","year":"2021","journal-title":"Eur J Cancer Prev"},{"key":"R30-20241021","doi-asserted-by":"crossref","first-page":"100202","DOI":"10.1016\/j.adoms.2021.100202","article-title":"Quality of health assessment in oral cancer patients postoperatively \u2013A retrospective study","volume":"5","author":"Mahalingam","year":"2022","journal-title":"Adv Oral Maxillofac Surg"},{"key":"R31-20241021","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/srmjrds.srmjrds_21_18","article-title":"Demographic and clinicopathological profile of oral squamous cell carcinoma patients of North India:A retrospective institutional study","volume":"9","author":"Tandon","year":"2018","journal-title":"SRM J Res Dent Sci"},{"key":"R32-20241021","first-page":"e759","article-title":"Socio-demographic characteristics are related to the advanced clinical stage of oral cancer","volume":"24","author":"Lins","year":"2019","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"R33-20241021","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.ijom.2020.03.009","article-title":"Oral squamous cell carcinoma:Epidemiological study and risk factor assessment based on a 39-year series","volume":"49","author":"Capote-Moreno","year":"2020","journal-title":"Int J Oral Maxillofac Surg"},{"key":"R34-20241021","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.OMX.0000469293.75530.0d","article-title":"Health-related quality of life in oral cancer survivors","volume":"6","author":"Musa","year":"2015","journal-title":"Egypt J Oral Maxillofac Surg"},{"key":"R35-20241021","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/annonc\/mdy040","article-title":"Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02)","volume":"29","author":"Tahara","year":"2018","journal-title":"Ann Oncol"},{"key":"R36-20241021","first-page":"407","article-title":"Concurrent chemoradiotherapy with intravenous cisplatin and docetaxel for advanced oral cancer","volume":"81","author":"Sato","year":"2019","journal-title":"Nagoya J Med Sci"},{"key":"R37-20241021","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejca.2019.12.019","article-title":"Is it time to redefine cisplatin ineligibility in metastatic urothelial cancer?","volume":"127","author":"Sridhar","year":"2020","journal-title":"Eur J Cancer"},{"key":"R38-20241021","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/cncr.23008","article-title":"Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy:A phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3)","volume":"110","author":"Rao","year":"2007","journal-title":"Cancer"},{"key":"R39-20241021","doi-asserted-by":"crossref","first-page":"6641963","DOI":"10.1155\/2021\/6641963","article-title":"Addition of nimotuzumab to standard TPF regimen in locally advanced Head and Neck Cancer:A Single Institutional Study","volume":"2021","author":"Koramati","year":"2021","journal-title":"J Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2179_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:39:04Z","timestamp":1787067544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2179_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_2179_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,22]]},"assertion":[{"value":"2022-10-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}